JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB4717

Anti-ABL1 (phospho Y412) antibody

Be the first to review this product! Submit a review

|

(9 Publications)

Rabbit Polyclonal ABL1 phospho Y412 antibody. Suitable for WB and reacts with Human samples. Cited in 9 publications. Immunogen corresponding to Synthetic Peptide within Human ABL1 phospho Y412.

View Alternative Names

ABL, JTK7, ABL1, Tyrosine-protein kinase ABL1, Abelson murine leukemia viral oncogene homolog 1, Abelson tyrosine-protein kinase 1, Proto-oncogene c-Abl, p150

2 Images
Western blot - Anti-ABL1 (phospho Y412) antibody (AB4717)
  • WB

Unknown

Western blot - Anti-ABL1 (phospho Y412) antibody (AB4717)

Peptide Competition :
Fibroblasts transfected with oncogenic ∆SH3-Abl were resolved by SDS-PAGE on a 10% polyacrylamide gel and transferred to PVDF. Membranes were blocked with a 5% BSA-TBST buffer overnight at 4°C, then were incubated with 0.50 μg/mL phospho c-Abl (Tyr 412) antibody for two hours at room temperature in a 3% BSA-TBST buffer, following prior incubation with : no peptide (1), the non-phosphopeptide corresponding to the immunogen (2), a generic phosphotyrosine containing peptide (3), or, the phosphopeptide immunogen (4). After washing, membranes were incubated with goat F(ab’)2 anti-rabbit IgG alkaline phosphatase and signals were detected using the Tropix WesternStar method. The data show that only the peptide corresponding to phospho c-Abl (Tyr 412) blocks the antibody signal, thereby demonstrating the specificity of the antibody.

Peptide Competition : Fibroblasts transfected with oncogenic ?SH3-Abl were resolved by SDS-PAGE on a 10%

All lanes:

Western blot - Anti-ABL1 (phospho Y412) antibody (ab4717)

Predicted band size: 122 kDa

false

Western blot - Anti-ABL1 (phospho Y412) antibody (AB4717)
  • WB

CiteAb

Western blot - Anti-ABL1 (phospho Y412) antibody (AB4717)

ABL1 (phospho Y412) western blot using anti-ABL1 (phospho Y412) antibody ab4717. Publication image and figure legend from Pandolfi, L., Fusco, R., et al., 2020, Sci Rep, PubMed 33244143.

ab4717 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab4717 please see the product overview.

Cytotoxic activity of GNP-HCIm and Imatinib (Im) alone on BOS-derived LFs. (A) Cell viability assay after 24, 48 and 72 h of treatment with GNP-HCIm and Im alone at the same concentration (10 μM). Data of two independent replicates (N = 10 for each condition) are represented as mean ± SD. (B) Quantification of apoptotic and necrotic cells after 48 h of treatment with GNP-HCIm and Im alone. Apoptotic cells were labeled with PE-Annexin V and necrotic cells with 7-AAD. Data of three independent replicates (N = 9 for each condition) are represented as mean ± SD. (C) Semiquantitative analysis of immunoblot of cAbl activity in BOS-derived cells after treatment with GNP-HCIm and Im alone for 24 h. Activity of cAbl was assessed by the quantification of phosphorylated protein related to total cAbl (cAbl-p/cAbl) normalizing results obtained after treatments with CTR cells. (D) representative immunoblot using antibodies specific for cAbl-p, or c-Abl or β-actin. Line 1 = CTR; line 2 = GNP-HCIm; line 3 = Im alone. Data of two independent replicates (N = 6 for each condition) are represented as mean ± SD. All graphs are made by Graphpad Prism 6.0; (https : //www.graphpad.com/scientific-software/prism/). All data were analyzed by one-way ANOVA followed by a Tukey post-hoc test for multiple comparisons. ***, p < 0.001 vs. CTR; **, p < 0.01 vs. CTR; ^, p < 0.001 vs. Im.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human ABL1 phospho Y412. The exact immunogen used to generate this antibody is proprietary information.

P00519

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-1 µg/mL", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Product details

c-Abl is a 140-150 kDa non-receptor protein tyrosine kinase whose precise functions are not known, but roles for Abl in growth factor and integrin signaling, cell cycle regulation, cytoskeletal reorganization, neurogenesis, and responses to DNA damage and oxidative stress have been suggested. c-Abl kinase activity is increased in vivo by diverse physiological stimuli including ionizing radiation, entry into S phase, integrin activation, and platelet-derived growth factor (PDGF) stimulation. c-Abl contains various protein binding domains that appear to enable it to regulate the functions of many proteins by forming complexes, most notably three isoforms of the oncogenic protein Bcr/Abl. c-Abl becomes fully activated by sequential phosphorylation of tyrosines 412 and 245.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Purified from rabbit serum by sequential epitope-specific chromatography. The antibody has been negatively pre-adsorbed using a non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated c-Abl. The final product is generated by affinity chromatography using a c-Abl derived peptide that is phosphorylated at tyrosine 245.
Storage buffer
pH: 7.3 Preservative: 0.05% Sodium azide Constituents: PBS, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ABL1 also referred to as ABL-1 or ABL1 protein is a non-receptor tyrosine kinase with a mass of approximately 120 kDa. It is found throughout the body in diverse tissues with significant expression in the brain testes and hematopoietic cells. This protein consists of several functional domains including SH3 SH2 and a kinase domain that facilitate its interaction with various cellular components. ABL1 kinase plays a central role in cell differentiation division and stress response reflecting its mechanical versatility in cellular signaling.
Biological function summary

ABL1 functions by regulating key processes like cell cycle progression actin dynamics and cell adhesion. ABL1 participates as part of larger protein complexes that modulate cellular movement and gene transcription. When activated it phosphorylates a range of substrates that leads to various cellular outcomes. ABL1 operates in the cytoplasm and nucleus influencing both cytoskeletal rearrangement and DNA repair which highlights its critical function in maintaining cellular integrity and response to damage.

Pathways

ABL1 interacts in both the mitogenic and apoptotic pathways including involvement in the MAPK and PI3K/AKT pathways. ABL1 interfaces with proteins like CRK and GRB2 in these pathways integrating signals that determine cell fate decisions. Through its kinase activity ABL1 mediates signaling cascades that impact cellular growth and survival responding dynamically to internal and external cues.

ABL1 is notoriously implicated in chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). The fusion protein BCR-ABL1 resulting from chromosomal translocation drives oncogenic signals that promote uncontrolled cell proliferation. The aberrant activity of BCR-ABL1 disrupts normal cellular regulation and interacts with proteins such as STAT5 enhancing leukemogenesis. Targeted therapies like tyrosine kinase inhibitors specifically hinder BCR-ABL1 activity demonstrating ABL1's importance in cancer pathology and treatment.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9 (PubMed : 22810897). Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717' (PubMed : 28428613). ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair : DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-153' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine-phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Regulates T-cell differentiation in a TBX21-dependent manner (By similarity). Positively regulates chemokine-mediated T-cell migration, polarization, and homing to lymph nodes and immune-challenged tissues, potentially via activation of NEDD9/HEF1 and RAP1 (By similarity). Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity (By similarity).
See full target information ABL1 phospho Y412

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Small science 5:2500144 PubMed40837040

2025

Hyaluronic Acid-Decorated Liposomes for the Intrapulmonary Delivery of Imatinib: A Targeted Treatment for Postinflammatory Pulmonary Fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Sara Bozzini,Valeria Bincoletto,Laura Pandolfi,Roberta Fusco,Rosanna Di Paola,Salvatore Cuzzocrea,Ilaria Andreana,Barbara Rolando,Eleonora Bozza,Cecilia Bagnera,Manuela Monti,Barbara Stella,Federica Meloni,Silvia Arpicco

Nature communications 12:504 PubMed33495460

2021

Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Huanjiao Jenny Zhou,Lingfeng Qin,Quan Jiang,Katie N Murray,Haifeng Zhang,Busu Li,Qun Lin,Morven Graham,Xinran Liu,Jaime Grutzendler,Wang Min

Scientific reports 10:20726 PubMed33244143

2020

Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Laura Pandolfi,Roberta Fusco,Vanessa Frangipane,Ramona D'Amico,Marco Giustra,Sara Bozzini,Monica Morosini,Maura D'Amato,Emanuela Cova,Giuseppina Ferrario,Patrizia Morbini,Miriam Colombo,Davide Prosperi,Simona Viglio,Davide Piloni,Rosanna Di Paola,Salvatore Cuzzocrea,Federica Meloni

Clinical cancer research : an official journal of 26:4349-4359 PubMed32439698

2020

AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Nellie K McDaniel,Mari Iida,Kwangok P Nickel,Colin A Longhurst,Samantha R Fischbach,Tamara S Rodems,Carlene A Kranjac,Amber Y Bo,Qianyun Luo,Meghan M Gallagher,Noah B Welke,Kaitlyn R Mitchell,Alison E Schulz,Jaimee C Eckers,Rong Hu,Ravi Salgia,Seungpyo Hong,Justine Y Bruce,Randall J Kimple,Deric L Wheeler

Journal of controlled release : official journal o 310:198-208 PubMed31430501

2019

Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Veronica Codullo,Emanuela Cova,Laura Pandolfi,Silvia Breda,Monica Morosini,Vanessa Frangipane,Manuela Malatesta,Laura Calderan,Maddalena Cagnone,Chiara Pacini,Lorenzo Cavagna,Helios Recalde,Jörg H W Distler,Marco Giustra,Davide Prosperi,Miriam Colombo,Federica Meloni,Carlomaurizio Montecucco

Genes & development 31:648-659 PubMed28446595

2017

DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Lucia Latella,Alessandra Dall'Agnese,Francesca Sesillo Boscolo,Chiara Nardoni,Marianna Cosentino,Armin Lahm,Alessandra Sacco,Pier Lorenzo Puri

Cell death and differentiation 20:987-97 PubMed23598363

2013

Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network.

Applications

Unspecified application

Species

Unspecified reactive species

S-Y Kim,M H Cordeiro,V A Serna,K Ebbert,L M Butler,S Sinha,A A Mills,T K Woodruff,T Kurita

Cell death and differentiation 18:1608-16 PubMed21455220

2011

Abl interconnects oncogenic Met and p53 core pathways in cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

A Furlan,V Stagni,A Hussain,S Richelme,F Conti,A Prodosmo,A Destro,M Roncalli,D Barilà,F Maina

Molecular biology of the cell 19:378-93 PubMed17959833

2007

Using Bcr-Abl to examine mechanisms by which abl kinase regulates morphogenesis in Drosophila.

Applications

WB

Species

Unspecified reactive species

Traci L Stevens,Edward M Rogers,Laura M Koontz,Donald T Fox,Catarina C F Homem,Stephanie H Nowotarski,Nicholas B Artabazon,Mark Peifer
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com